APA (7th ed.) Citation

Yang, Y., Wang, J., Wang, W., Zhang, T., Zhao, J., Wang, Y., . . . Bi, N. (2022, January). Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Frontiers in Oncology.

Chicago Style (17th ed.) Citation

Yang, Yin, Jianyang Wang, Wenqing Wang, Tao Zhang, Jingjing Zhao, Yu Wang, Yexiong Li, Luhua Wang, and Nan Bi. "Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis." Frontiers in Oncology Jan. 2022.

MLA (9th ed.) Citation

Yang, Yin, et al. "Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis." Frontiers in Oncology, Jan. 2022.